Inicio › Trastorno depresivo mayor › Alabama
Ensayos clínicos de Trastorno depresivo mayor en Alabama
15 estudios sobre Trastorno depresivo mayor buscan participantes en Alabama.
Ciudades en Alabama
Texto oficial del estudio (inglés)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- UAB Psychiatry and Behavioral Neurology, Birmingham
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- University of Alabama at Birmingham, Birmingham
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07227454A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- University of Alabama at Birmingham - School of Medicine, Birmingham
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Alabama at Birmingham, Huntsville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05850689Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06966401Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- University of Alabama, Birmingham
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07226661Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07226232Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Alabama at Birmingham - Dept. of Psychiatry, Birmingham
Reclutando
Edades de 22 a 70 · Todos los sexos · Actualizado el 16 oct 2026 · NCT06423430NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- University of Alabama at Birmingham, Birmingham
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06547489Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
ReclutandoSe aceptan voluntarios sanos
Edades de 10 a 24 · Todos los sexos · Actualizado el 13 jul 2026 · NCT05437588A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Harmonex /ID# 277517, Dothan
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 15 jun 2026 · NCT07276997MicroRNA Correlates of Childhood Maltreatment and Suicidality
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 60 · Todos los sexos · Actualizado el 30 mar 2026 · NCT04923685Using TMS to Understand Neural Processes of Social Motivation
- Auburn University, Auburn
Reclutando
Edades de 25 a 50 · Todos los sexos · Actualizado el 3 mar 2026 · NCT06274112Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #131, Birmingham
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 20 ene 2026 · NCT06633016De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.